Form 4: Checkpoint Therapeutics CFO Sells Shares to Cover Tax Obligations

William Garrett Gray, CFO of Checkpoint Therapeutics, sold 2,035 shares of common stock on February 28, 2024, to cover tax obligations related to vesting restricted stock.

Summary

• On February 28, 2024, William Garrett Gray, the Chief Financial Officer of Checkpoint Therapeutics, Inc., sold 2,035 shares of the company's common stock.
• The sale was executed to cover Mr. Gray's tax withholding obligations associated with the vesting of 3,925 shares of restricted stock.
• The shares were sold at a weighted average price of $2.07, with individual prices ranging from $2.07 to $2.075.
• Mr. Gray had no discretion over the sale, which was transacted automatically according to company policy.
• Following the transaction, Mr. Gray beneficially owns 145,224 shares, including restricted common stock that vests over time.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine transaction to cover tax obligations, not indicative of a major positive or negative event.

Industry Context

This is a routine transaction related to tax obligations from vesting restricted stock, a common practice among company executives. It doesn't necessarily indicate a change in the executive's confidence in the company.

Key Dates